PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.25%
Revenue growth above 1.5x BRZE's 4.50%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
8.43%
Gross profit growth above 1.5x BRZE's 3.98%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
18.60%
Positive EBIT growth while BRZE is negative. John Neff might see a substantial edge in operational management.
18.60%
Positive operating income growth while BRZE is negative. John Neff might view this as a competitive edge in operations.
23.79%
Positive net income growth while BRZE is negative. John Neff might see a big relative performance advantage.
312.05%
EPS growth at 75-90% of BRZE's 347.83%. Bill Ackman would push for improved profitability or share repurchases to catch up.
312.05%
Diluted EPS growth at 75-90% of BRZE's 347.83%. Bill Ackman would expect further improvements in net income or share count reduction.
0.92%
Share count expansion well above BRZE's 0.69%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.92%
Diluted share count expanding well above BRZE's 0.69%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
98.78%
Positive OCF growth while BRZE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
138.00%
Positive FCF growth while BRZE is negative. John Neff would see a strong competitive edge in net cash generation.
24.90%
10Y revenue/share CAGR under 50% of BRZE's 241.59%. Michael Burry would suspect a lasting competitive disadvantage.
24.90%
5Y revenue/share CAGR under 50% of BRZE's 241.59%. Michael Burry would suspect a significant competitive gap or product weakness.
24.90%
3Y revenue/share CAGR under 50% of BRZE's 110.03%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
138.54%
Positive long-term OCF/share growth while BRZE is negative. John Neff would see a structural advantage in sustained cash generation.
138.54%
Positive OCF/share growth while BRZE is negative. John Neff might see a comparative advantage in operational cash viability.
138.54%
Positive 3Y OCF/share CAGR while BRZE is negative. John Neff might see a big short-term edge in operational efficiency.
48.55%
Positive 10Y CAGR while BRZE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
48.55%
Positive 5Y CAGR while BRZE is negative. John Neff might view this as a strong mid-term relative advantage.
48.55%
Positive short-term CAGR while BRZE is negative. John Neff would see a clear advantage in near-term profit trajectory.
170.11%
Equity/share CAGR of 170.11% while BRZE is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
170.11%
Equity/share CAGR of 170.11% while BRZE is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
170.11%
Below 50% of BRZE's 441.59%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.04%
Firm’s AR is declining while BRZE shows 15.37%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.92%
Inventory growth of 1.92% while BRZE is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
2.07%
Similar asset growth to BRZE's 1.99%. Walter Schloss finds parallel expansions or investment rates.
2.63%
BV/share growth above 1.5x BRZE's 0.22%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-1.99%
We’re deleveraging while BRZE stands at 4.77%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
0.67%
We increase R&D while BRZE cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
2.00%
SG&A declining or stable vs. BRZE's 9.26%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.